Anti-EGFR antibody plus anti-PD-1 antibody and chemotherapy as a neoadjuvant regimen for patients with locally-advanced penile squamous cell carcinoma: A prospective, single-arm, single-center, phase II clinical trial.
JOURNAL OF CLINICAL ONCOLOGY（2022）
关键词
chemotherapy,anti-egfr,locally-advanced,single-arm,single-center
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要